Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Wednesday lulv io

WePeB5894 Residual HIV-i disease eradication (rhide) trial:
an HIV-1 reservoir eradication approach in
humans using stimulatory and novel
intensification therapy
RJ Pomerantz M Otero, G Nunnari, A Malin,
C Coates, C Dascenzo, J DeSimone, TJ Babinchak,
H Zhang, G Dornadula, D Culnan, J Sullivan, YXu,
I Stern, W Cavert, A T Haase, J Kulkosky
(United States)
WePeB5895 Treatment with a combination of Efavirenz,
Nevirapine and NRTIs in HIV patients
A Arranz-Caso M Gorgolas, V Estrada,
J D Garcia-Diaz (Spain)
WePeB5896 Long-term follow-up of 21 subjects carrying
multinucleoside-resistant genotypes (Q151M,
67/69 inserts, deletion 67)
0 Gallego (Spain)
WePeB5897 Youth and Survival: developing a life-skills
curriculum to assist HIV affected, infected and atrisk youth with transitional process into
adulthood
K C Sanchez (United States)
WePeB5898 Extended treatment interruption in HIV-infected
patients with maximal viral suppression
CAchenbach M Deloria Knoll, M Till, S Terp,
F Palella, A Kalnins, R Murphy (United States)
WePeB5899 Antiviral potency and tolerability of a convenient
once a day direct observed therapy with
amprenavir containing haart regimen in an
antiretroviral naive, inner-city minority patients
with poor HIV knowledge and very advanced
AlIDS
D Jayaweera T Tanner, A M Nowak, M Brill,
J Pottage, R Campo, A Rodriquez, M Kolber
(United States)
WePeB59oo The effect of mycophenolic acid and ribavirin on
the anti-HIV activity of amdoxovir (DAPD)
I Harris, K Borroto-Esoda, F Myrick, G Painter
(United States)
WePeB5901ol Protease inhibitor-sparing regimens containing
nevirapine, Efavirenz, or Abacavir achieve longterm HIV-1 Aviremia and CD4 stabilization but do
not improve metabolic complications
P Greiger-Zanlungo, G Blick, T Garton,
S Sharfuddin, ZArzu (United States)
WePeB59o2 Efficacy of switching from a protease inhibitor
(PI) based highly active antiretroviral therapy
(HAART) to a once daily saquinavir (SQV) and low
dose ritonavir (RTV) dosing regimen in
conjunction with therapeutic drug monitoring
(TDM)
J G Baril, P Cote, S Dufresne, P Junod, F Laplante,
M A Charron (Venezuela)
WePeB59o3 Patient choice consensus protocol of
ZDV/3TC/ABC (Trizivir) + efavirenz or
ZDV/3TC/ABC (Trizivir) + nelfinavir for the
treatment of antiretroviral naive H IV-i+ patients
R G Hewitt T Olatinwo, L D Esch (United States)
WePeB59o4 Lopinavir/ritonavir-Efavirenz: preliminary
assessment of a potent nucleoside-sparing dual
antiretroviral regimen (the BIKS study)
C Allavena, A Lafeuillade, M Bentata, 0 Launay,
MA Valantin, I M Besnier, C Rabreau, A S Poirier,
E Dailly, F Raffi (France)
WePeB59o5 Short-cycle of structured treatment interruption
of antiretroviral therapy in chronic H IV infection
G D'Offizi, S Topino, R Bellagamba, A R Garbuglia,

S Calcaterra, M R Capobianchi, V Tozzi, P Narciso
(Italy)

WePeB59o6 HIV in the amniotic fluid of term pregnancies
TJ Tucker B Mohlala, M Besser, R Burton,
C Williamson, J Anthony (South Africa)
WePeB59o7 Project of Adhesion to the anti-retroviral
treatment
V K Rosa, N T Barcellos, R Fonseca, S S Schuh
(Brazi)
WePeB59o8 The construction of public policies to decrease
HIV transmission from mother to child in Rio
Grande do Sul, Brazil
D S Gaio SM Bueno, V K Rosa, E Matos,
L Mondini, G Rigotti, N T Barcellos (Brazil)
WePeB59o9 Abacavir use in HIV-positive Pregnant Women
A M Puga, M L Brown, S M Widmayer
(United States)
WePeB591o Determinants and trends of HIV vertical
transmission in the Metropolitan area of Belo
Horizonte, Brazil, January/1996 to
December/2000
FM Kakehasi, L FAleixo, D B F Quental,
C P Rezende, D B Greco, JA Pinto (Brazil)
WePeB5911 Co-infection with Toxoplasma gondii in a cohort
of HIV infected pregnant women
S A Noaueiral, ES Machado', T P Costal,
T FAbreu1, A L Gaspar, MA Maan', A L Guedes1,
JS Lambert2 Brazil; 2United States)
WePeB5912 Changes over time in the use of antiretrovirals to
prevent vertical transmission of HIV
S A Noqueira, ES Machado', T P Costa', TAbreu',
M Tavares', I S Lambert2 Brazil; 2United States)
WePeB5913 Antiretroviral Drug Resistance and Subtype
Distribution in the Vertical Transmission of HIV-1
IE Souza, M L Azevedo, R M Succi, D M Machado,
R S Diaz (Brazil)
WePeB5914 Mother-to-Child HIV transmission rates in
exclusively breastfed, mixed-fed and formula fed
infants of the Dominican Republic
N Diaz, C Soto, G Minervino, S Soto, E Cruz,
E Perez-Then (Dominican Republic)
WePeB5915 Voluntary counselling and HIV testing in
Southern Brazil
M Z GoldanP, EJ Giugliani', H C Rosa', T Scanlon2,
A Tomkins2 (Brazil; 2United Kingdom)
WePeB5916 Use of rapid anti-H IV tests as a strategy to
improve screening among pregnant women in Rio
de Janeiro City, Brasil
B Durovni, V Saraceni, CS Rapparini, A F Fonseca
(Brazil)
WePeB5917 An update of protease inhibitor (PI) use in 233
pregnancies
AB Morris A Rua Dobles, C Zorrilla, J R Anderson,
S Cu-Uvin, J Keller, J / Harwell, J L Garb
(United States)
WePeB5918 Effectiveness of nevirapine and zidovudine use in
the prevention of perinatal transmission of H IV in
Uganda
F Ba unirwe, S Asiimwe, M Kamya, E] Arts2,
/ Massaquo, C C Whalen2 (Uganda; 2United
States)
WePeB5919 Antiretroviral genotypic resistance patterns In
HIV infected pregnant women in the Bronx, New
York, USA
] P McGowan S S Shah, M Crane, K Monaghan
(United States)
WePeB592o Prevention of milk-borne transmission of HIV in
Botswana: the Mashi study
I Thior, C Wester S Lockman, R Shapiro,

J Heymann, T Peter, E Widenfelt, MASHI site
teams, R Marlink, M Essex (Botswana)

Wednesday

XIV International AIDS Conference BARCELONA - JULY 7-12

161